CERTAIN INFORMATION IDENTIFIED WITH THE MARK “(***)” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 13th, 2024 • Avalo Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 13th, 2024 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of December 6, 2023 (the “Effective Date”), by and among AlmataBio, Inc., a Delaware corporation (the “Buyer”), Leap Therapeutics, Inc., a Delaware corporation (“Parent”), and Flame Biosciences LLC, a Delaware limited liability company (“Flame” and, together with Parent, the “Sellers”).
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 13th, 2024 • Avalo Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 13th, 2024 Company IndustryThis First Amendment to the License Agreement (the “Amendment”) is dated February 2, 2021, and amends that certain License Agreement dated November 25, 2019 between Flame Biosciences, Inc., a Delaware corporation with a place of business at 280 Union Square Drive, New Hope, Pennsylvania 18938 (“Flame”), and Eli Lilly and Company, having an address at Lilly Corporate Center, Indianapolis, Indiana, 46285, United States of America (“Lilly”) (such agreement, the “Agreement”). Flame and Lilly may be referred to herein individually as a “Party” or collectively as the “Parties”.
LICENSE AGREEMENT by and between FLAME BIOSCIENCES, INC. and ELI LILLY and COMPANYLicense Agreement • May 13th, 2024 • Avalo Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 13th, 2024 Company Industry JurisdictionThis License Agreement (the “Agreement”), is entered into as of November 25th, 2019 (the “Signing Date”), is entered into by and between FLAME BIOSCIENCES, INC., a Delaware corporation with a place of business at 555 Madison Ave, Suite 1201, New York, NY 10022 (“Flame”), and ELI LILLY AND COMPANY, an Indiana corporation with a place of business at Lilly Corporate Center, Indianapolis, Indiana, 46285 (“Lilly”). Flame and Lilly may be referred to herein individually as a “Party” or collectively as the “Parties”.